By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS


Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte Corporation 

Maxygen, Inc. 

Intergen Company 





Company News
Emisphere Technologies, Inc. (EMIS) Highlights Positive Phase 2 Og217sc Data From Eligen Licensee Novo Nordisk A/S (NVO) 2/23/2015 7:19:25 AM
Novo Nordisk A/S (NVO) Announces Positive Results For Phase 2 Trial With Oral Semaglutide In People With Type 2 Diabetes 2/20/2015 6:34:34 AM
Shares Surge as Novo Nordisk A/S (NVO) Shows Off Positive Trial Data for Oral Insulin 2/20/2015 6:33:51 AM
International GPCR Consortium Announces Addition Of New Members International Food Information Council And Novo Nordisk A/S (NVO) 2/10/2015 8:08:58 AM
Sanofi (SAN.PA) Reshuffles, Ups Headcount of Diabetes Unit to Regain Ground Against Novo Nordisk A/S (NVO) 2/6/2015 5:48:32 AM
TransCelerate BioPharma Welcomes Merck & Co. (MRK) And Novo Nordisk A/S (NVO) To Its Membership Roster 1/27/2015 8:23:24 AM
Novo Nordisk A/S (NVO) Receives FDA Approval For Norditropin® Flexpro® 30 Mg/3.0 Ml For Patients With Growth Hormone Disorders 1/27/2015 7:31:00 AM
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014 6:28:57 AM
Novo Nordisk A/S (NVO) Already Seeking Successor for CEO That Will Most Likely Step Down in 2019 12/29/2014 6:16:30 AM
Novo Nordisk A/S (NVO) Receives FDA Approval For Saxenda® For The Treatment Of Obesity 12/24/2014 6:07:42 AM
12345678910...
//-->